João Mendes1,2,3,4*
Ana Luísa Areia1,2,3,4,5
Paulo Rodrigues-Santos1,2,4,6,7Manuel Santos-Rosa6
Anabela Mota-Pinto1,2,3,4- 1Faculty of Medicine, Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, Coimbra, Portugal
- 2Faculty of Medicine, Center of Investigation in Environment, Genetics and Oncobiology (CIMAGO), University of Coimbra, Coimbra, Portugal
- 3Faculty of Medicine, General Pathology Institute, University of Coimbra, Coimbra, Portugal
- 4Center for Innovation in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal
- 5Obstetrics Department, Coimbra University Hospital Center, Coimbra, Portugal
- 6Faculty of Medicine (FMUC), Institute of Immunology, University of Coimbra, Coimbra, Portugal
- 7Center for Neuroscience and Cell Biology (CNC), Laboratory of Immunology and Oncology, University of Coimbra, Coimbra, Portugal
Innate lymphoid cells (ILCs) are a new set of cells considered to be a part of the innate immune system. ILCs are classified into five subsets (according to their transcription factors and cytokine profile) as natural killer cells (NK cells), group 1 ILCs, group 2 ILCs, group 3 ILCs, and lymphoid tissue inducers (LTi). Functionally, these cells resemble the T helper population but lack the expression of recombinant genes, which is essential for the formation of T cell receptors. In this work, the authors address the distinction between peripheral and decidual NK cells, highlighting their diversity in ILC biology and its relevance to human pregnancy. ILCs are effector cells that are important in promoting immunity, inflammation, and tissue repair. Recent studies have directed their attention to ILC actions in pregnancy. Dysregulation or expansion of pro-inflammatory ILC populations as well as abnormal tolerogenic responses may directly interfere with pregnancy, ultimately resulting in pregnancy loss or adverse outcomes. In this review, we characterize these cells, considering recent findings and addressing knowledge gaps in perinatal medicine in the context of ILC biology. Moreover, we discuss the relevance of these cells not only to the process of immune tolerance, but also in disease.
Introduction
From the immunology point of view, we may consider the fetus as a semi-allograft concept initially put forward in 1953 by Sir Peter Medawar (1). Accordingly, taken from the knowledge attained in transplantation science, the trophoblast carrying paternal antigens must invade the maternal uterine mucosa, in a process called implantation, while escaping immune defense mechanisms against the alloantigen. This is the first paradox in the biology of pregnancy (2).
Indeed, there are three major phases in pregnancy, involving the immunologic response: implantation of the trophoblast, widely regarded as an inflammatory process; followed by a protective anti-inflammatory milieu, needed throughout the whole development of the fetus; and finally, labor itself, which is also regarded as an inflammatory event (3–9). During pregnancy, differences in inflammatory states relate to different cytokine profiles. Evidence in the literature supports a shift from a T helper 1 (Th1) cytokine profile to a Th2 profile favoring a humoral response (10). However, other cell types contribute to the immune regulation of pregnancy, such as T regulatory cells, IL-17-producing cells, and tissue resident cells (11, 12).
The majority of scientific investigation has focused on the T cell repertoire and on the balance between Th1, Th2, and Th17 cytokines (13–16); nonetheless, it is evident that the innate component of the immune system has a preponderant role in pregnancy (17, 18). Moreover, the classic Th1/Th2 paradigm fails to explain the immunomodulatory actions of locally secreted cytokines.
In this review, we focus on innate immune responses during pregnancy, considering a recently categorized set of cells called innate lymphoid cells (ILCs).
Innate Lymphoid Cells
ILCs are a group of cells that share a common lymphoid progenitor. ILCs are characterized by the absence of recombination-activating gene (RAG)-dependent rearranged antigen receptors and the lack of myeloid and dendritic cell phenotypical markers, hence denominated as lineage negative (Lin-). ILC1s, ILC2s, and ILC3s are dependent on transcription factors T-bet, GATA-3, and RORγt, respectively. Moreover, natural killer (NK) cells are dependent on the transcription factors eomesodermin (Eomes) and T-bet for their development. These cells share the expression of a common γ chain, IL-7Rα (CD127), except for tonsil and intraepithelial ILC1 (19). In addition, ILC2 is characterized by the expression IL-2Rα (CD25), a receptor that is also present in CD56bright NK cells but has a lower expression in ILC1 and ILC3 (19, 20). They are functionally diverse and belong to the innate component of the immune system (20). A summarized diagram of ILCs is presented in Figure 1.
Figure 1 This figure depicts a proposed model for the differentiation paths of ILCs, highlighting the similarities with Th cells regarding common transcription factors. A common lymphoid progenitor (CLP), originated from a hematopoietic stem cell (HSC) can give rise to adaptive and innate lymphocytes. However, it should be noted that this figure was simplified to convey the message that Th cells and ILCs are of lymphoid origin because Th cell populations do not differentiate directly from CLPs. Downstream of the CLP, a common ILC precursor (CILP) then divides into 1) a branch that differentiates into NK cells and 2) a branch that generates a common helper-ILC precursor (CHILP). The CHILP further differentiates toward a different branch of the ILC family, namely ILC1, ILC2, and ILC3, and generates an LTi population. This figure highlights similarities between ILCs and Th cells. The classification of ILCs is based on functional criteria. ILCs functionally resemble adaptive lymphocytes with the distinction that ILCs lack antigen-specific receptors. Instead, ILCs are known to exert their effects through the production of cytokines and cell surface molecules with important consequences for tissue homeostasis, inflammation, and disease. Dysregulation or expansion of pro-inflammatory ILC populations may directly promote disease through production of pro-inflammatory cytokines, which seems to be important in the pathogenesis of PTL. T-bet, T-box transcription factor 21; Eomes, eomesodermin; CRTH2, Chemoattractant receptor-homologous molecule expressed on TH2 cells; GATA3, GATA binding protein 3; AHR, aryl hydrocarbon receptor; ROR, Retinoic acid–related orphan receptor; IFNγ, interferon-γ; IL, interleukin; LTi, lymphoid tissue inducer; NCR, natural cytotoxicity receptor; NK, natural killer; PTL, Preterm labor.
ILCs were initially classified as NK cells in 1975 (21); afterward, in 1997, another cell type was added, named lymphoid tissue inducer (LTi) (22). Although NK cells represent cytotoxic ILCs capable of killing virus-infected or tumor cells and releasing pro-inflammatory cytokines (23), LTi are critical for the development of secondary lymphoid organs during embryogenesis (24). However, in the context of pregnancy, there are significant differences regarding NK function, which we address further on in this review.
ILCs play an essential role in tissue homeostasis, defense against infection and inflammation, and tissue repair (25). ILCs are mainly tissue-resident cells found in the mucosal surfaces (26) as well as in the decidua of pregnant women (27).
ILCs were classified based on their relative cytokine profiles, centered on effector phenotypes that mirror T helper cells. Over the years, the classification of ILCs has been the subject of great debate, mainly due to their heterogeneity. However, the nomenclature approved by the International Union of Immunological Societies (IUIS) considers five distinct groups: NK cells known to produce IFN-γ; group 1 (ILC1), also known to produce IFN-γ, a Th1-like cytokine; group 2 (ILC2), which are characterized by the expression of transcription factor Gata3 and the ability to produce Th2-like cytokines; group 3 (ILC3), known to produce IL-22 and IL-17; and LTis, important in secondary lymphoid organ formation (19, 25).
Moreover, it has become evident that ILCs have great plasticity. Their effector characteristics are highly dependent on their microenvironment, mainly on the cytokines secreted by tissue-resident cells, and other cells from the innate immune system (28). Due to the ability of some ILCs to produce pro-inflammatory cytokines and to the fact that ILCs express MHCII molecules, their importance in the regulation of labor is rational.
Immune tolerance and controlled inflammation are key processes in a successful pregnancy. Dysregulated inflammatory reactions often lead to complications, such as spontaneous abortion, preterm labor (PTL), preeclampsia, and intrauterine growth restriction (10, 29).
NK Cells and ILC1
The importance of NK cells in pregnancy is paramount, not only because these cells belong to the innate immune system, but also because NK cells play an important role in placentation, remodeling of the spinal arteries, and control of trophoblast invasion (30–33). Decidual NK (dNK) cells differ substantially from peripheral NK cells: peripheral NK cells are predominantly CD56dim CD16+, and dNK cells are CD56bright CD16- (23, 34). This phenotype is accompanied by functional differences because CD56dim CD16+ cells have a strong cytolytic activity, and dNK cells are predominately cytokine-producing cells.
One key feature of dNK cells is their inability to lyse trophoblastic cells despite the expression of activating receptors (NKp46, NKp30, NKG2D, and DNAM-1) as well as their perforin and granzyme content. Instead, they produce IL-8, stromal cell–derived factor 1 (SDF-1), vascular endothelial growth factor (VEGF), and interferon gamma-induced protein 10 (IP-10), all with important roles in tissue remodeling (30, 35–37). Even though NK cells were discovered many years ago, it is only more recently that these cells were included in the ILC group. Recent work by Vento-Tormo et al. proposed three main dNK subsets: dNK1, dNK2, and dNK3 cells. This classification has been further confirmed by Huhn et al. (38, 39). Also, previous work by Yudanin et al., conducted in tissues other than uterine origin, highlights the overlapping characteristics of NK cells with ILC1, a fact also reported by Huhn et al., and this raises the question, are dNK3 subsets in fact ILC1 (40)? The nature and consequent nomenclature of the different dNK subsets and ILC1 are still a matter of great dispute.
Classically, uterine ILC1 are characterized by the expression of T-bet and Eomes and produce IFN-γ. ILC1 do not express perforin and have the inability to produce Th2- and Th17-type cytokines (27, 41). ILC1 have diverse regulatory actions dependent on the cell type and on the stimuli received (42–44).
ILC1 can be further characterized by their surface markers CD56-, CD94-, CD127+, CD117-, and they have been identified in low numbers in human decidua (27), suggesting a minor role in pregnancy (45).
Group 2 ILCs
Group 2 ILCs are phenotypically characterized by the surface markers CD56-, CD127+, and CD161+ and chemoattractant receptor homologous molecules expressed on Th2 cells (CRTH2) (27, 43). ILC2 are dependent on GATA binding protein 3 and transcription factor retinoid-related orphan receptor alpha (RORα) for their development (20, 46). ILC2 produce type 2 cytokines (IL-4, IL-5, and IL-13) under the control of IL-25 and IL-33, which is important in extracellular parasitic infections and allergic responses (19). The expression of CRTH2 is of great interest for labor because it is a G protein–coupled receptor for prostaglandin D2, which promotes ILC2 differentiation and type 2 pro-inflammatory responses (47). Another important feature of the ILC2 population, found in a study conducted in a mouse model, is the expression of major histocompatibility complex class II (MHCII) as well as the co-stimulatory molecules CD80 and CD86 (48). In this study conducted by Oliphant et al., it is shown that ILC2 can not only perform endocytosis, but also process and present antigens (48). These characteristics allow ILC2 to present antigens to T CD4+ cells and induce proliferation toward a Th2 phenotype in an IL-2-dependent manner (48). These data, albeit conducted in mouse models, reinforce the notion of cross-talk between the innate and the adaptive immune systems (49–51).
Group 3 ILCs
Group 3 ILCs are characterized by the expression of the surface marker CD117 and the transcription factor RORγt. In a mouse model, it was proven that ILC3 express MHC class II, and they are also shown to promote T cell–mediated responses (52). Two different studies suggest that ILC3 might promote neutrophil activation with pro-angiogenic abilities, contributing to the inflammatory phase needed for implantation (53, 54). ILC3 can be further divided based on the presence of the natural cytotoxic receptor (NCR) NKp44. ILC3 NCR+ produce IL-22, and ILC3 NCR- produce IL-17 (55, 56); both subsets have been found in human decidua (27). NCR is also present in activated peripheral NK cells and dNK. In NK cells, NCRs mediate cytotoxic (57) and antitumor responses (58); however, when present in uterine NK cells, NCR receptors have an important role in placentation through the production of IL-8, VEGF, IP-10, and SDF-1 (36).
The ability of ILC3 to act as pro-inflammatory agents (through the secretion of IL-17) suggests a preponderant role in pregnancy, which both favors embryo implantation and has an antimicrobial effect. In fact, decidual ILC3 seem to be important to pregnancy maintenance through innate defenses and tissue remodeling (27). Nevertheless, the inappropriate release of pro-inflammatory cytokines during the quiescent phase of pregnancy may prompt complications, mainly the precocious activation of the normal mechanism of labor.
ILCs in Uterine and Fetal Compartments
Male et al. first made the distinction between uterine NK cells and ILC subsets in humans. In this work, ILCs were first considered precursors of uterine NK cells; however, these cells showed differences in function and phenotype through the expression of RAR related orphan receptor C (RORC), Lymphotoxin α, and IL2 genes (59), which were later attributed to ILC3 and LTi subsets. Subsequent studies identified ILC1 (60), ILC2 (61), and ILC3 (60, 61) in human endometrium and decidua based on evidence that ILCs share a common lymphoid progenitor.
ILC1 can be found in the endometrium and decidua of pregnant women as early as 9–12 weeks of gestation (27), representing an important source of IFN-γ (60) and implying a relevant role in the immune response against intracellular pathogens. In addition, the expression of CD103, an adhesion molecule that promotes the communication between lymphocytes and epithelial cells, suggests an epithelial localization of ILC1 in the endometrium and decidua (27).
Xu et al. show that, in term pregnancies, ILC2 is the most abundant population in the human decidua, and it is capable of producing Th2-type cytokines, such as IL-4, IL-5, and IL-13. In this study, the authors suggest that the pro-inflammatory qualities of ILC2 might underlie the pathological process prompting PTL (45). Specifically, Xu et al. argue that ILC populations dynamically change throughout pregnancy. In fact, they also detected ILC3 in the decidua parietalis that are capable of producing IL-17 and IL-22, suggesting that these cells may be responsible for inflammation-driven PTL.
ILC3 were also initially described as a subset of NK cells in the human endometrium, expressing CD127, CD161, RORC, and IL-22 (59). Later, work by Vacca et al. confirmed the ILC3 phenotype and their presence in the human endometrium and decidua during pregnancy and further divided them into two subgroups: ILC3 NKp44+ and ILC3 NKp44- (27, 60). It is shown that, similarly to Th cells, ILCs display some degree of plasticity in response to their microenvironment. Studies conducted in mouse models show that, in response to IL-12 and IL-18, ILC3 reveal an increased expression of T-bet and decreased expression of RORγt, which results in IFN-γ production and loss of their capacity to produce IL-17 and IL-22 (62, 63). These data may explain, in part, the low numbers of ILC1 found by Xu et al. in late gestation due to overlapping functions with ILC3 phenotypes.
Amniotic fluid surrounds the embryo and fetus, protecting it mechanically during development in the event of the maternal abdomen being subject to trauma. Amniotic fluid also protects the fetus from infectious agents due to its inherent antibacterial properties (64). Amniotic fluid provides the fetus with a reservoir of fluid, nutrients, and growth factors that allow normal development and growth of fetal organs (64). The main population identified in this compartment is ILC3 of fetal origin, expressing CD127, CD117, CD161, and CD56 (64). Indeed, ILC3 are abundant in the amniotic fluid until the second trimester (64), when their numbers start to decay as gestation progresses (65). In this context, the ability of ILC3 to produce IL17 suggests a role in regulating intra-amniotic infection (64).
Fetal ILCs have been identified in the liver, secondary lymphoid organs (SLOs), intestine, lungs, and cord blood (66, 67). In the liver, ILCs assume a preponderant role because it is in this organ that hematopoiesis takes place (68, 69) and where ILC precursors (ILCPs) originate (66). In their work, Lim et al. suggest that circulating ILCP can migrate to different tissues, where they differentiate according to fetal development needs and organogenesis (66). Moreover, studies from animal models suggest that the presence of LTi cells in the fetus is essential for the successful formation of SLOs, such as the spleen, mesenteric lymph nodes, and Peyer’s patches (70–73).
Previous work has demonstrated that NK, ILC1, ILC2, and ILC3 subsets can be readily identified in the human fetal intestine (55, 64, 74, 75). It is shown that intestinal ILC2 produce IL-13 (74), and ILC3 and LTi-like cells produce IL-17A and IL-22 (55).
Mjösberg et al. report the presence of ILC2 in the fetal lung (74), and Marquardt et al. have detected increased numbers of ILC3 in the second trimester when compared to the first trimester (64).
Most of the information available regarding ILCs comes from animal models. However considering the great degree of similarity between mouse and human ILC ontology (19), we attempted a reasonable extrapolation to human biology.
The ubiquity of ILCs present in the uterine and fetal compartment denotes the importance of the innate immune system in pregnancy. Not only do ILCs take part in organ formation, but they also act as key mediators in protecting the fetus against infection and pathogens. The main findings that are the object of this review are summarized in Table 1.
Table 1 Main findings in the literature regarding human ILCs in uterine and fetal compartments.
Innate Lymphoid Cells and the Induction of Tolerance
In order to escape the maternal immune system, trophoblast cells only express human leukocyte antigen (HLA) HLA-C, the nonclassical HLA-E, HLA-F, and HLA-G molecules (77–80).
In pregnancy, one key mechanism regulating induction of tolerance is through the actions of HLA-G molecules. The HLA-G gene is located at chromosome 6 within the class I gene cluster of MHC. HLA-G belongs to the nonclassical HLA-class I (or class Ib) genes; it is expressed mainly in the fetal–maternal interface on the extravillous cytotrophoblast (81), amnion (82), and thymus (83), and its soluble form is detectable in peripheral blood (84).
HLA-G exerts its effects by modulating antigen-presenting cells (85), suppressing proliferation of CD4+ T lymphocytes (86, 87), and inhibiting NK cells’ actions. In fact, HLA-G inhibits NK cells’ (84) cytolytic actions, upregulates NK inhibitory receptors (88), and is essential for implantation (89).
Also, in this perspective, there is evidence that progesterone, a key immunomodulatory steroid hormone, contributes to a pregnancy protective milieu by promoting HLA-G expression (90) and regulating NK activity (91) (92).
Tolerance is widely regarded as an adaptive response. Accordingly, it is a process that involves antigen presentation, clonal expansion, and the formation of memory cells; the expression of HLA class II molecules in ILC2 and ILC3 populations suggests that these cells might also have a role in pregnancy by presenting paternal antigens to the mother’s immune system. Although ILC2 seem capable of eliciting Th proliferation, Hepworth et al. reported, in animal models, that ILC3 lack classical costimulatory molecules, such as CD40, CD80, and CD86. If this is the case, ILC3 antigen presentation may, in fact, limit T cell responses by negatively regulating CD4+ T cell responses in vivo through T cell anergy (49, 93).
Whether ILCs are on the forefront in establishing tolerance toward the fetus is a matter that requires further research.
Innate Lymphoid Cells in Disease
Studies in NK cell biology corroborate the involvement of the innate immune system in preterm birth (PTB), preeclampsia, fetal growth restriction, and morbidly adherent placentation as well as spontaneous abortion (94–99). Dysregulation or expansion of pro-inflammatory ILC populations may directly promote disease through production of pro-inflammatory cytokines, namely IL-17, which are considered important in the pathogenesis of preeclampsia and PTB (76). Moreover, high levels of IL-18 and IFN-γ have been associated with preeclampsia (100), and in PTB, there is evidence for an inadequate inflammatory response (101).
Progesterone has been known to play an important role in reproductive health for the initiation and maintenance of pregnancy with good results in the prevention of spontaneous abortion and recently in PTL (102–104).
The immunosuppressive effects of progesterone have been recognized for a long time. Despite its mode of action remaining largely unknown, progesterone has been widely adopted by clinicians around the world for prevention of PTB. Our group has already demonstrated that progesterone modulates the human T regulatory cell population during pregnancy (13, 102, 105, 106). There is also evidence, conducted in a small sample of T cell clones, suggesting that progesterone favors Th2 while dampening Th1 and Th17 responses and, thus, participates in the establishment of a favorable environment for pregnancy by its effects on T cells (107). Work from Henderson et al. shows that NK cells do not express progesterone receptors (108); however, the expression of CRTH2 in ILC2 suggests that ILCs are subject to hormonal regulation. Also, work done by Gibson et al. (109) shows that uNK cells are regulated by membrane estradiol receptors (E46), highlighting the relevance of hormone regulation in NK activity during pregnancy.
Conclusion
Human ILCs are mainly tissue resident with relevant roles in mediating infection, inflammation, and tissue repair. Namely, ILC1 are known to promote immunity to intracellular pathogens and are associated with inflammatory bowel disease (110). ILC2 support antiparasite immunity and play an important role in airway inflammation (111). ILC3 are essential in immunity against extracellular pathogens and skin inflammation (112) and mediating graft-versus-host (113). In the past 10 years, we have witnessed a growing interest in ILC biology and their role in pregnancy. Future work, focusing on endocrine and environmental factors influencing ILC phenotype, will contribute to answer unsolved questions in clinical practice.
Author Contributions
JM: Scientific analysis, manuscript writing and editing. Areia: Writing and supervision of scientific content PR-S: Manuscript writing and supervising all the scientific analysis. MS-R: Writing and supervision of scientific content. AM-P: Coordination of research group, supervision of scientific content. All authors contributed to the article and approved the submitted version.
Funding
This work was financed by Centro de Investigação em Meio Ambiente, Genética e Oncobiologia (CIMAGO) of the Faculty of Medicine of Coimbra University, through Grant Number 06/14.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1. Medawar PB. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates. Symp Soc Exp Biol (1953).
2. Chavan AR, Griffith OW, Wagner GP. The inflammation paradox in the evolution of mammalian pregnancy: turning a foe into a friend. Curr Opin Genet Dev (2017) 47:24–32. doi: 10.1016/j.gde.2017.08.004
3. Hanssens S, Salzet M, Vinatier D. Immunological aspect of pregnancy. J Gynecol Obstet Biol La Reprod (2012) 41:595–611. doi: 10.1016/j.jgyn.2012.07.001
4. Thaxton JE, Nevers TA, Sharma S. TLR-mediated preterm birth in response to pathogenic agents. Infect Dis Obstet Gynecol (2010) 2010:378472. doi: 10.1155/2010/378472
5. Dekel N, Gnainsky Y, Granot I, Racicot K, Mor G. The role of inflammation for a successful implantation. Am J Reprod Immunol (2014) 72:141–7. doi: 10.1111/aji.12266
6. Bollopragada S, Youssef R, Jordan F, Greer I, Norman J, Nelson S. Term labor is associated with a core inflammatory response in human fetal membranes, myometrium, and cervix. Am J Obstet Gynecol (2009) 200:104.e1–104.e11. doi: 10.1016/j.ajog.2008.08.032
7. Hadfield KA, McCracken SA, Ashton AW, Nguyen TG, Morris JM. Regulated suppression of NF-κB throughout pregnancy maintains a favourable cytokine environment necessary for pregnancy success. J Reprod Immunol (2011) 89:1–9. doi: 10.1016/j.jri.2010.11.008
8. van Mourik MSM, Macklon NS, Heijnen CJ. Embryonic implantation: cytokines, adhesion molecules, and immune cells in establishing an implantation environment. J Leukoc Biol (2008) 85:4–19. doi: 10.1189/jlb.0708395
9. Graham C, Chooniedass R, Stefura WP, Becker AB, Sears MR, Turvey SE, et al. In vivo immune signatures of healthy human pregnancy: Inherently inflammatory or anti-inflammatory? PloS One (2017) 12:1–16. doi: 10.1371/journal.pone.0177813
10. Gilman-Sachs A, Dambaeva S, Salazar Garcia MD, Hussein Y, Kwak-Kim J, Beaman K. Inflammation induced preterm labor and birth. J Reprod Immunol (2018) 129:53–8. doi: 10.1016/j.jri.2018.06.029
11. Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and Regulatory T-Cell Paradigm in Pregnancy. Am J Reprod Immunol (2010) 63:601–10. doi: 10.1111/j.1600-0897.2010.00852.x
12. Southcombe J, Tannetta D, Redman C, Sargent I. The immunomodulatory role of syncytiotrophoblast microvesicles. PloS One (2011) 6(5):e20245. doi: 10.1371/journal.pone.0020245
13. Areia AL, Vale-Pereira S, Vaz-Ambrósio A, Alves V, Rodrigues-Santos P, Rosa MS, et al. Does progesterone administration in preterm labor influence Treg cells? J Perinat Med (2016) 44:605–11. doi: 10.1515/jpm-2015-0134
14. Monteiro C, Kasahara TM, Castro JR, Sacramento PM, Hygino J, Centurião N, et al. Pregnancy favors the expansion of circulating functional follicular helper T Cells. J Reprod Immunol (2017) 121:1–10. doi: 10.1016/j.jri.2017.04.007
15. Huang Y, Mao K, Germain RN. Thinking differently about ILCs—Not just tissue resident and not just the same as CD4+ T-cell effectors. Immunol Rev (2018) 286:160–71. doi: 10.1111/imr.12704
16. Figueiredo AS, Schumacher A. The T helper type 17/regulatory T cell paradigm in pregnancy. Immunology (2016) 148:13–21. doi: 10.1111/imm.12595
17. Areia AL, Moura P, Mota-Pinto A. The role of innate immunity in spontaneous preterm labor: A systematic review. J Reprod Immunol (2019) 136:102616. doi: 10.1016/j.jri.2019.102616
18. Faas MM, De Vos P. Innate immune cells in the placental bed in healthy pregnancy and preeclampsia. Placenta (2018) 69:125–33. doi: 10.1016/j.placenta.2018.04.012
19. Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate Lymphoid Cells: 10 Years On. Cell (2018) 174:1054–66. doi: 10.1016/j.cell.2018.07.017
20. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol (2013) 13:145–9. doi: 10.1038/nri3365
21. Kiessling R, Klein E, Wigzell H. “Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol (1975) 5:112–7. doi: 10.1002/eji.1830050208
22. Sleckman BP, Bardon CG, Ferrini R, Davidson L, Alt FW. Function of the TCRα enhancer in αβ and γδ T cells. Immunity (1997) 7:505–15. doi: 10.1016/S1074-7613(00)80372-6
23. Caligiuri MA. Human natural killer cells. Blood (2008) 112:461–9. doi: 10.1182/blood-2007-09-077438
24. Zhong C, Zheng M, Zhu J. Lymphoid tissue inducer—A divergent member of the ILC family. Cytokine Growth Factor Rev (2018) 42:5–12. doi: 10.1016/j.cytogfr.2018.02.004
25. Artis D, Spits H. The biology of innate lymphoid cells. Nature (2015) 517:293–301. doi: 10.1038/nature14189
26. Klose CSN, Artis D. Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat Immunol (2016) 17:765–74. doi: 10.1038/ni.3489
27. Vacca P, Montaldo E, Croxatto D, Loiacono F, Canegallo F, Venturini PL, et al. Identification of diverse innate lymphoid cells in human decidua. Mucosal Immunol (2015) 8:254–64. doi: 10.1038/mi.2014.63
28. Diefenbach A, Colonna M, Koyasu S. Development, differentiation, and diversity of innate lymphoid cells. Immunity (2014) 41:354–65. doi: 10.1016/j.immuni.2014.09.005
29. Kalagiri RR, Carder T, Choudhury S, Vora N, Ballard AR, Govande V, et al. Inflammation in Complicated Pregnancy and Its Outcome. Am J Perinatol (2016) 33:1337–56. doi: 10.1055/s-0036-1582397
30. Hanna J, Goldman-Wohl D, Hamani Y, Avraham I, Greenfield C, Natanson-Yaron S, et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med (2006) 12:1065–74. doi: 10.1038/nm1452
31. Zhang Y, Wang Y, Wang XH, Zhou WJ, Jin LP, Li MQ. Crosstalk between human endometrial stromal cells and decidual NK cells promotes decidualization in vitro by upregulating IL-25. Mol Med Rep (2018) 17:2869–78. doi: 10.3892/mmr.2017.8267
32. González IT, Barrientos G, Freitag N, Otto T, Thijssen VLJL, Moschansky P, et al. Uterine NK Cells Are Critical in Shaping DC Immunogenic Functions Compatible with Pregnancy Progression. PloS One (2012) 7:1–10. doi: 10.1371/journal.pone.0046755
33. Rätsep MT, Felker AM, Kay VR, Tolusso L, Hofmann AP, Croy BA. Uterine natural killer cells: Supervisors of vasculature construction in early decidua basalis. Reproduction (2015) 149:R91–R102. doi: 10.1530/REP-14-0271
34. Pietra G, Vacca P, Moretta L, Prefumo F, Mingari MC. Analysis of Natural Killer Cells Isolated from Human Decidua: Evidence that 2B4 (CD244) Functions as an Inhibitory Receptor and Blocks NK Cell Function. Clin Immunol (2007) 123:S187. doi: 10.1016/j.clim.2007.03.555
35. Jacobs R, Hintzen G, Kemper A, Beul K, Kempf S, Behrens G, et al. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur J Immunol (2001) 31:3121–6. doi: 10.1002/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4
36. Vacca P, Cantoni C, Prato C, Fulcheri E, Moretta A, Moretta L, et al. Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells. Int Immunol (2008) 20:1395–405. doi: 10.1093/intimm/dxn105
37. Sharma S, Godbole G, Modi D. Decidual Control of Trophoblast Invasion. Am J Reprod Immunol (2016) 75:341–50. doi: 10.1111/aji.12466
38. Vento-Tormo R, Efremova M, Botting RA, Turco MY, Vento-Tormo M, Meyer KB, et al. Single-cell reconstruction of the early maternal–fetal interface in humans. Nature (2018) 563:347–53. doi: 10.1038/s41586-018-0698-6
39. Huhn O, Ivarsson MA, Gardner L, Hollinshead M, Stinchcombe JC, Chen P, et al. Distinctive phenotypes and functions of innate lymphoid cells in human decidua during early pregnancy. Nat Commun (2020) 11:381. doi: 10.1038/s41467-019-14123-z
40. Yudanin NA, Schmitz F, Flamar AL, Thome JJC, Tait Wojno E, Moeller JB, et al. Spatial and Temporal Mapping of Human Innate Lymphoid Cells Reveals Elements of Tissue Specificity. Immunity (2019) 50:505–19. doi: 10.1016/j.immuni.2019.01.012
41. Montaldo E, Vacca P, Vitale C, Moretta F, Locatelli F, Mingari MC, et al. Human innate lymphoid cells. Immunol Lett (2016) 179:2–8. doi: 10.1016/j.imlet.2016.01.007
42. Zhang J, Marotel M, Fauteux-Daniel S, Mathieu AL, Viel S, Marçais A. Walzer T. T-bet and Eomes govern differentiation and function of mouse and human NK cells and ILC1. Eur J Immunol (2018) 48:738–50. doi: 10.1002/eji.201747299
43. Hazenberg MD, Spits H. Review Article Human innate lymphoid cells. Blood (2014) 124:700–10. doi: 10.1182/blood-2013-11-427781.There
44. Kallies A, Good-Jacobson KL. Transcription Factor T-bet Orchestrates Lineage Development and Function in the Immune System. Trends Immunol (2017) 38:287–97. doi: 10.1016/j.it.2017.02.003
45. Xu Y, Romero R, Miller D, Silva P, Panaitescu B, Theis KR, et al. Innate lymphoid cells at the human maternal-fetal interface in spontaneous preterm labor. Am J Reprod Immunol (2018) 79:e12820. doi: 10.1111/aji.12820
46. Mjösberg J, Bernink J, Golebski K, Karrich JJ, Peters CP, Blom B, et al. The Transcription Factor GATA3 Is Essential for the Function of Human Type 2 Innate Lymphoid Cells. Immunity (2012) 37:649–59. doi: 10.1016/j.immuni.2012.08.015
47. Xue L, Salimi M, Panse I, Mjösberg JM, McKenzie ANJ, Spits H, et al. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol (2014) 133(4):1184–94. doi: 10.1016/j.jaci.2013.10.056
48. Oliphant CJ, Hwang YY, Walker JA, Salimi M, Wong SH, Brewer JM, et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4+ T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity (2014) 41:283–95. doi: 10.1016/j.immuni.2014.06.016
49. Hepworth MR, Monticelli LA, Fung TC, Ziegler CGK, Grunberg S, Sinha R, et al. Innate lymphoid cells regulate CD4 + T-cell responses to intestinal commensal bacteria. Nature (2013) 498:113–7. doi: 10.1038/nature12240
50. Halim TYF, Steer CA, Mathä L, Gold MJ, Martinez-Gonzalez I, McNagny KM, et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity (2014) 40:425–35. doi: 10.1016/j.immuni.2014.01.011
51. Maizels RM, Withers DR. MHC-II: A mutual support system for ILCs and T cells? Immunity (2014) 41:174–6. doi: 10.1016/j.immuni.2014.07.006
52. Von Burg N, Chappaz S, Baerenwaldt A, Horvath E, Bose Dasgupta S, Ashok D, et al. Activated group 3 innate lymphoid cells promote T-cell-mediated immune responses. Proc Natl Acad Sci U S A (2014) 111:12835–40. doi: 10.1073/pnas.1406908111
53. Amsalem H, Kwan M, Hazan A, Zhang J, Jones RL, Whittle W, et al. Identification of a Novel Neutrophil Population: Proangiogenic Granulocytes in Second-Trimester Human Decidua. J Immunol (2014) 193:3070–9. doi: 10.4049/jimmunol.1303117
54. Croxatto D, Micheletti A, Montaldo E, Orecchia P, Loiacono F, Canegallo F, et al. Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua. Mucosal Immunol (2016) 9:1372–83. doi: 10.1038/mi.2016.10
55. Hoorweg K, Peters CP, Cornelissen F, Aparicio-Domingo P, Papazian N, Kazemier G, et al. Functional differences between human NKp44- and NKp44+ RORC+ innate lymphoid cells. Front Immunol (2012) 3:72. doi: 10.3389/fimmu.2012.00072
56. Mjösberg J, Spits H. Human innate lymphoid cells. J Allergy Clin Immunol (2016) 138:1265–76. doi: 10.1016/j.jaci.2016.09.009
57. Cantoni C, Bottino C, Vitale M, Pessino A, Augugliaro R, Malaspina A, et al. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med (1999) 189:787–95. doi: 10.1084/jem.189.5.787
58. Vitale M, Bottino C, Sivori S, Sanseverino L, Castriconi R, Marcenaro E, et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med (1998) 187:2065–72. doi: 10.1084/jem.187.12.2065
59. Male V, Hughes T, McClory S, Colucci F, Caligiuri MA, Moffett A. Immature NK Cells, Capable of Producing IL-22, Are Present in Human Uterine Mucosa. J Immunol (2010) 185:3913–8. doi: 10.4049/jimmunol.1001637
60. Montaldo E, Vacca P, Chiossone L, Croxatto D, Loiacono F, Martini S, et al. Unique Eomes+ NK cell subsets are present in uterus and decidua during early pregnancy. Front Immunol (2016) 6:646. doi: 10.3389/fimmu.2015.00646
61. Doisne J-M, Balmas E, Boulenouar S, Gaynor LM, Kieckbusch J, Gardner L, et al. Composition, Development, and Function of Uterine Innate Lymphoid Cells. J Immunol (2015) 195:3937–45. doi: 10.4049/jimmunol.1500689
62. Klose CSN, Kiss EA, Schwierzeck V, Ebert K, Hoyler T, D’Hargues Y, et al. A T-bet gradient controls the fate and function of CCR6-RORγt + innate lymphoid cells. Nature (2013) 494:261–5. doi: 10.1038/nature11813
63. Klose CSN, Flach M, Möhle L, Rogell L, Hoyler T, Ebert K, et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell (2014) 157:340–56. doi: 10.1016/j.cell.2014.03.030
64. Marquardt N, Ivarsson MA, Sundström E, Åkesson E, Martini E, Eidsmo L, et al. Fetal CD103 + IL-17–Producing Group 3 Innate Lymphoid Cells Represent the Dominant Lymphocyte Subset in Human Amniotic Fluid. J Immunol (2016) 197:3069–75. doi: 10.4049/jimmunol.1502204
65. Gomez-Lopez N, Romero R, Xu Y, Miller D, Leng Y, Panaitescu B, et al. The immunophenotype of amniotic fluid leukocytes in normal and complicated pregnancies. Am J Reprod Immunol (2018) 79:1–17. doi: 10.1111/aji.12827
66. Lim AI, Li Y, Lopez-Lastra S, Stadhouders R, Paul F, Casrouge A, et al. Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation. Cell (2017) 168:1086–100.e10. doi: 10.1016/j.cell.2017.02.021
67. Forkel M, Berglin L, Kekäläinen E, Carlsson A, Svedin E, Michaëlsson J, et al. Composition and functionality of the intrahepatic innate lymphoid cell-compartment in human nonfibrotic and fibrotic livers. Eur J Immunol (2017) 47:1280–94. doi: 10.1002/eji.201646890
68. Pahal GS, Jauniaux E, Kinnon C, Thrasher AJ, Rodeck CH. Normal development of human fetal hematopoiesis between eight and seventeen weeks’ gestation. Am J Obstet Gynecol (2000) 183:1029–34. doi: 10.1067/mob.2000.106976
69. Rollini P, Hull EFVT., Kaiser S, Kapp U, Leyvraz S. Phenotypic and functional analysis of human fetal liver hematopoietic stem cells in culture. Stem Cells Dev (2007) 16:281–95. doi: 10.1089/scd.2006.0096
70. Yoshida H, Honda K, Shinkura R, Adachi S, Nishikawa S, Maki K, et al. IL-7 receptor α+ CD3- cells in the embryonic intestine induces the organizing center of Peyer’s patches. Int Immunol (1999) 11:643–55. doi: 10.1093/intimm/11.5.643
71. Eberl G, Marmon S, Sunshine MJ, Rennert PD, Choi Y, Littmann DR. An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells. Nat Immunol (2004) 5:64–73. doi: 10.1038/ni1022
72. Tan JKH, Watanabe T. Murine Spleen Tissue Regeneration from Neonatal Spleen Capsule Requires Lymphotoxin Priming of Stromal Cells. J Immunol (2014) 193:1194–203. doi: 10.4049/jimmunol.1302115
73. Hoorweg K, Narang P, Li Z, Thuery A, Papazian N, Withers DR, et al. A Stromal Cell Niche for Human and Mouse Type 3 Innate Lymphoid Cells. J Immunol (2015) 195:4257–63. doi: 10.4049/jimmunol.1402584
74. Mjösberg JM, Trifari S, Crellin NK, Peters CP, Van Drunen CM, Piet B, et al. Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol (2011) 12:1055–62. doi: 10.1038/ni.2104
75. Li N, van Unen V, Höllt T, Thompson A, van Bergen J, Pezzotti N, et al. Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine. J Exp Med (2018) 215:1383–96. doi: 10.1084/jem.20171934
76. Barnie PA, Lin X, Liu Y, Xu H, Su Z. IL-17 producing innate lymphoid cells 3 (ILC3) but not Th17 cells might be the potential danger factor for preeclampsia and other pregnancy associated diseases. Int J Clin Exp Pathol (2015) 8:11100–7.
77. King A, Burrows TD, Hiby SE, Bowen JM, Joseph S, Verma S, et al. Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta (2000) 21:376–87. doi: 10.1053/plac.1999.0496
78. Hackmon R, Pinnaduwage L, Zhang J, Lye SJ, Geraghty DE, Dunk CE. Definitive class I human leukocyte antigen expression in gestational placentation: HLA-F, HLA-E, HLA-C, and HLA-G in extravillous trophoblast invasion on placentation, pregnancy, and parturition. Am J Reprod Immunol (2017) 77:1–11. doi: 10.1111/aji.12643
79. Apps R, Murphy SP, Fernando R, Gardner L, Ahad T, Moffett A. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology (2009) 127:26–39. doi: 10.1111/j.1365-2567.2008.03019.x
80. Ellis SA, Sargent IL, Redman CW, McMichael AJ. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology (1986) 59(4):595–601.
81. Goldman-Wohl DS, Ariel I, Greenfield C, Hanoch J, Yagel S. HLA-G expression in extravillous trophoblasts is an intrinsic property of cell differentiation: A lesson learned from ectopic pregnancies. Mol Hum Reprod (2000) 6:535–40. doi: 10.1093/molehr/6.6.535
82. Li J, Koike-Soko C, Sugimoto J, Yoshida T, Okabe M, Nikaido T. Human amnion-derived stem cells have immunosuppressive properties on NK cells and monocytes. Cell Transplant (2015) 24:2065–76. doi: 10.3727/096368914X685230
83. Mallet V, Blaschitz A, Crisa L, Schmitt C, Fournel S, King A, et al. HLA-G in the human thymus: A subpopulation of medullary epithelial but not CD83+ dendritic cells expresses HLA-G as a membrane-bound and soluble protein. Int Immunol (1999) 11:889–98. doi: 10.1093/intimm/11.6.889
84. Hunt JS, Geraghty DE. Soluble HLA-G isoforms: Technical deficiencies lead to misinterpretations. Mol Hum Reprod (2005) 11:715–7. doi: 10.1093/molehr/gah223
85. LeMaoult J, Krawice-Radanne I, Dausset J, Carosella ED. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci U S A (2004) 101:7064–9. doi: 10.1073/pnas.0401922101
86. Bainbridge DRJ, Ellis SA, Sargent IL. HLA-G suppresses proliferation of CD4+ T-lymphocytes. J Reprod Immunol (2000) 48:17–26. doi: 10.1016/S0165-0378(00)00070-X
87. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: A CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A (2001) 98:12150–5. doi: 10.1073/pnas.201407398
88. Lemaoult J, Zafaranloo K, Le Danff C, Carosella ED. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J (2005) 19:1–23. doi: 10.1096/fj.04-1617fje
89. Fuzzi B, Rizzo R, Criscuoli L, Noci I, Melchiorri L, Scarselli B, et al. HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy. Eur J Immunol (2002) 32:311–5. doi: 10.1002/1521-4141(200202)32:2<311::AID-IMMU311>3.0.CO;2-8
90. Yie SM, Li LH, Li GM, Xiao R, Librach CL. Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro. Hum Reprod (2006) 21:46–51. doi: 10.1093/humrep/dei305
91. Laškarin G, Tokmadži VS, Štrbo N, Bogovi T, Szekeres-Bartho J, Randi L, et al. Progesterone induced blocking factor (PIBF) mediates progesterone induced suppression of decidual lymphocyte cytotoxicity. Am J Reprod Immunol (2002) 48:201–9. doi: 10.1034/j.1600-0897.2002.01133.x
92. Dosiou C, Giudice LC. Natural killer cells in pregnancy and recurrent pregnancy loss: Endocrine and immunologic perspectives. Endocr Rev (2005) 26:44–62. doi: 10.1210/er.2003-0021
93. Schwartz RH. T cell anergy. Annu Rev Immunol (2003) 21:305–34. doi: 10.1146/annurev.immunol.21.120601.141110
94. Fukui A, Yokota M, Funamizu A, Nakamua R, Fukuhara R, Yamada K, et al. Changes of NK Cells in Preeclampsia. Am J Reprod Immunol (2012) 67:278–86. doi: 10.1111/j.1600-0897.2012.01120.x
95. St. Louis D, Romero R, Plazyo O, Arenas-Hernandez M, Panaitescu B, Xu Y, et al. Invariant NKT Cell Activation Induces Late Preterm Birth That Is Attenuated by Rosiglitazone. J Immunol (2016) 196:1044–59. doi: 10.4049/jimmunol.1501962
96. Fu B, Zhou Y, Ni X, Tong X, Xu X, Dong Z, et al. Natural Killer Cells Promote Fetal Development through the Secretion of Growth-Promoting Factors. Immunity (2017) 47:1100–13.e6. doi: 10.1016/j.immuni.2017.11.018
97. Laban M, Ibrahim EAS, Elsafty MSE, Hassanin AS. Placenta accreta is associated with decreased decidual natural killer (dNK) cells population: A comparative pilot study. Eur J Obstet Gynecol Reprod Biol (2014) 181:284–8. doi: 10.1016/j.ejogrb.2014.08.015
98. Varla-Leftherioti M, Spyropoulou-Vlachou M, Keramitsoglou T, Papadimitropoulos M, Tsekoura C, Graphou O, et al. Lack of the appropriate natural killer cell inhibitory receptors in women with spontaneous abortion. Hum Immunol (2005) 66:65–71. doi: 10.1016/j.humimm.2004.10.005
99. Varla-Leftherioti M, Spyropoulou-Vlachou M, Niokou D, Keramitsoglou T, Darlamitsou A, Tsekoura C, et al. Natural killer (NK) cell receptors’ repertoire in couples with recurrent spontaneous abortions. Am J Reprod Immunol (2003) 49:183–91. doi: 10.1034/j.1600-0897.2003.00018.x
100. Yang Y, Su X, Xu W, Zhou R. Interleukin-18 and Interferon Gamma Levels in Preeclampsia: A Systematic Review and Meta-analysis. Am J Reprod Immunol (2014) 72:504–14. doi: 10.1111/aji.12298
101. Romero R, Miranda J, Chaiworapongsa T, Korzeniewski SJ, Chaemsaithong P, Gotsch F, et al. Prevalence and Clinical Significance of Sterile Intra-amniotic Inflammation in Patients with Preterm Labor and Intact Membranes. Am J Reprod Immunol (2014) 72:458–74. doi: 10.1111/aji.12296
102. Areia A, Fonseca E, Moura P. Progesterone use after successful treatment of threatened pre-term delivery. J Obstet Gynaecol (Lahore) (2013) 33:678–81. doi: 10.3109/01443615.2013.820266
103. Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: A multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol (2011) 38:18–31. doi: 10.1002/uog.9017
104. Romero R, Nicolaides K, Conde-Agudelo A, Tabor A, O’Brien JM, Cetingoz E, et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: A systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol (2012) 206:124.e1–124.e19. doi: 10.1016/j.ajog.2011.12.003
105. Areia A, Vale-Pereira S, Alves V, Rodrigues-Santos P, Moura P, Mota-Pinto A. Membrane progesterone receptors in human regulatory T cells: A reality in pregnancy. BJOG Int J Obstet Gynaecol (2015) 122:1544–50. doi: 10.1111/1471-0528.13294
106. Areia A, Vale-Pereira S, Alves V, Rodrigues-Santos P, Santos-Rosa M, Moura P, et al. Can membrane progesterone receptor α on T regulatory cells explain the ensuing human labour? J Reprod Immunol (2016) 113:22–6. doi: 10.1016/j.jri.2015.10.002
107. Piccinni MP, Giudizi MG, Biagiotti R, Beloni L, Giannarini L, Sampognaro S, et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol (1995) 155:128–33.
108. Henderson TA, Saunders PTK, Moffett-King A, Groome NP, Critchley HOD. Steroid receptor expression in uterine natural killer cells. J Clin Endocrinol Metab (2003) 88:440–9. doi: 10.1210/jc.2002-021174
109. Gibson DA, Esnal-Zufiaurre A, Bajo-Santos C, Collins F, Critchley HOD, Saunders PTK. Profiling the expression and function of oestrogen receptor isoform ER46 in human endometrial tissues and uterine natural killer cells. Hum Reprod (2020) 35(3):641–51. doi: 10.1093/humrep/dez306
110. Geremia A, Arancibia-Cárcamo CV, Fleming MPP, Rust N, Singh B, Mortensen NJ, et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med (2011) 208:1127–33. doi: 10.1084/jem.20101712
111. Smith SG, Chen R, Kjarsgaard M, Huang C, Oliveria JP, O’Byrne PM, et al. Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. J Allergy Clin Immunol (2016) 137:75–86.e8. doi: 10.1016/j.jaci.2015.05.037
112. Villanova F, Flutter B, Tosi I, Grys K, Sreeneebus H, Perera GK, et al. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J Invest Dermatol (2014) 134:984–91. doi: 10.1038/jid.2013.477
Keywords: innate lymphoid cells, innate immune response, inflammation, pregnancy, preterm birth
Citation: Mendes J, Areia AL, Rodrigues-Santos P, Santos-Rosa M and Mota-Pinto A (2020) Innate Lymphoid Cells in Human Pregnancy. Front. Immunol. 11:551707. doi: 10.3389/fimmu.2020.551707
Received: 14 April 2020; Accepted: 28 October 2020;
Published: 30 November 2020.
Edited by:
A. Inkeri Lokki, University of Helsinki, FinlandReviewed by:
Taruna Madan, National Institute for Research in Reproductive Health (ICMR), IndiaHrishikesh Pandit, National Cancer Institute at Frederick, United States
Victoria Male, Imperial College London, United Kingdom
Copyright © 2020 Mendes, Areia, Rodrigues-Santos, Santos-Rosa and Mota-Pinto. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: João Mendes, jmendes@uc.pt